N-Boc Linagliptin
| Product Name | N-Boc Linagliptin |
|---|---|
| Alternate Names | Linagliptin Impurities, Impurities of Linagliptin |
| CAT No. | CS-T-68140 |
| CAS No. | 668273-75-4 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 572.66 g/mol |
| Mol. For. | C30H36N8O4 |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Linagliptin |
| Therapeutic | Anti-Diabetic |
| Smileys | CC#CCN1C2=C(N=C1N3CCCC(C3)NC(=O)OC(C)(C)C)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C |
| Canonical Smiles | CC#CCN1C2=C(N=C1N3CCCC(C3)NC(=O)OC(C)(C)C)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C |
| InchIKey | PQEIZFATTRGTNW-HXUWFJFHSA-N |
| Inchl | InChI=1S/C30H36N8O4/c1-7-8-16-37-24-25(34-27(37)36-15-11-12-20(17-36)32-28(40)42-30(3,4)5)35(6)29(41)38(26(24)39)18-23-31-19(2)21-13-9-10-14-22(21)33-23/h9-10,13-14,20H,11-12,15-18H2,1-6H3,(H,32,40)/t20-/m1/s1 |
| IUPAC | tert-butyl N-[(3R)-1-[7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,6-dioxopurin-8-yl]piperidin-3-yl]carbamate |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
N-Boc Linagliptin is a chemical compound that is used in the pharmaceutical industry as an active ingredient in the production of drugs for the treatment of type 2 diabetes. It belongs to a class of drugs known as Dipeptidyl Peptidase-4 (DPP-4) inhibitors. These inhibitors work by preventing the breakdown of incretin hormones in the body, which helps to regulate blood sugar levels.
Chemically, N-Boc Linagliptin is a white to off-white, crystalline powder that is sparingly soluble in water. Its chemical formula is C34H41N7O5, and it has a molecular weight of 639.74 g/mol. The compound is stable under normal storage conditions and has a shelf life of up to three years.
N-Boc Linagliptin is usually administered orally in tablet form, either alone or in combination with other diabetes medications. The recommended dose is 5 mg once daily, with or without food. It is important to follow the prescribed dose and frequency as directed by a healthcare provider to ensure adequate control of blood glucose levels.
Overall, N-Boc Linagliptin is an effective and safe medication for the management of type 2 diabetes. Its chemical properties and mechanism of action make it a valuable tool in the treatment of this chronic condition.
Get an Instant Quote
Related Compounds
Linagliptin Dimer Impurity | Linagliptin Impurity 42 | Linagliptin Dimer Impurity 4 | Linagliptin Impurity 75 HCl salt | Linagliptin impurity S | Linagliptin impurity 115 | Linagliptin impurity 14 | Linagliptin Impurity II | N-(6-Amino-1,2,3,4-tetrahydro-1-methyl-2,4-dioxo-5-pyrimidinyl)formamide | Linagliptin Impurity 41 | Linagliptin Impurity T | Linagliptin Pentahydroxy Impurity | Linagliptin Impurity G | Linagliptin tert-butyl carbamate | Desbutyl N-nitroso Linagliptin Impurity 52 | Linagliptin Impurity N | Linagliptin-4-methylquinazolin-2-yl-methyl dimer | Linagliptin impurity E | Linagliptin Impurity 41 | Linagliptin Impurity 40 | N-Hydroxy Linagliptin | Linagliptin impurity X | Linagliptin Impurity 117 | N-Phthalimide-linagliptin | Linagliptin Impurity Q | N-nitroso linagliptin impurity 92 | Linagliptin Impurity 4 | Linagliptin Impurity 2 | Linagliptin impurity P | Linagliptin N-Amino Acyl Impurity | Linagliptin Impurity 25 | Linagliptin Impurity 9 | Linagliptin Impurity-VII | Linagliptin Dimer Impurity | Linagliptin Impurity 38 | Linagliptin impurity C | Linagliptin impurity J | Linagliptin Impurity 29 | Linagliptin Impurity W | Linagliptin N-Acetyl Impurity | Linagliptin Impurity 43 | Linagliptin Diene Impurity | Linagliptin impurity K | Linagliptin Impurity 1 | Linagliptin Impurity 36 | Linagliptin impurity H | Linagliptin impurity F | Linagliptin Impurity 49 | Linagliptin Impurity 37 | Hydroxy Methyl Linagliptin | Linagliptin-d9 | Desalkyl N-nitroso Linagliptin | Linagliptin impurity Y | Desmethyl N-nitroso Linagliptin | Linagliptin Dimer impurity (N-C-C-C Dimer) | Bromobutene Linagliptin impurity VII | Linagliptin Glycosamine | Linagliptin Impurity 35 | Linagliptin Impurity 51 | Desbutyl N-nitroso Linagliptin impurity 16 | N-Formyl Linagliptin | Linagliptin impurity O | Linagliptin Impurity 76 TrisHCl salt | Linagliptin Impurity 17 | N-nitroso Linagliptin Impurity C | Linagliptin Impurity I | Linagliptin Impurity 3 | Linagliptin impurity V | Linagliptin Impurity D | Linagliptin impurity U |